Adjunctive Treatment of Major Depressive Disorder
4 clinical trials · Condition
◉ Watch Adjunctive Treatment of Major Depressive Disorder
| Record | Firm | Date |
|---|---|---|
| A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study (NCT04103892) | Clexio Biosciences Ltd. | 2019-09-05 |
| Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (NCT04000009) | ACADIA Pharmaceuticals Inc. | 2019-06-06 |
| Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (NCT03968159) | ACADIA Pharmaceuticals Inc. | 2019-04-25 |
| Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY) (NCT03018340) | ACADIA Pharmaceuticals Inc. | 2016-12-01 |
Track Adjunctive Treatment of Major Depressive Disorder automatically
Every clearance here is in the API, with alerts when new ones post.